TEK and neoplasm: This pathway is active in the vasculature of B16F10 tumors as TIE2 is broadly phosphorylated in the endothelial cells of B16F10 tumors (Fig 1I) and TIE2 phosphorylation persists in the tumor vasculature of mice treated with SHP099 (Fig EV4D).